Chrystal Louis
Directeur Technique/Scientifique/R&D chez TSCAN THERAPEUTICS, INC.
Postes actifs de Chrystal Louis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 08/04/2024 | - |
Historique de carrière de Chrystal Louis
Anciens postes connus de Chrystal Louis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2022 | 01/03/2024 |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Corporate Officer/Principal | 01/07/2020 | 01/11/2022 |
| CELGENE | Corporate Officer/Principal | 01/10/2016 | 01/01/2019 |
Formation de Chrystal Louis
| Southwestern University | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| ZENTALIS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
- Bourse
- Insiders
- Chrystal Louis
- Expérience
